News | News Detail

Understanding the clinical pharmacology of antiretroviral therapy is pivotal to designing optimal treatment and prevention strategies for HIV infection.  We know that drug exposure is significantly influenced by drug interactions, non-adherence, and patients’ physiologic and genetic characteristics.  These factors are central to determining therapeutic efficacy, failure or toxicity.  Despite great progress, many pharmacologic challenges still exist.

The 10th edition of the International Workshop on Clinical Pharmacology will present the current state of the art on the use of antiretroviral agents in preventing and curing HIV infection, in addition to predicting important toxicities, antiretroviral challenges in an aging population, and antiretroviral use in resource-poor countries.  The workshop will also provide a comprehensive update of current topics fundamental to the optimal use of antiretroviral therapy, such as newly detected drug-drug interactions, pharmacokinetics of investigational agents, drug dosing in special populations, and post-marketing surveillance projects.

For this, our 10th anniversary, we return to the Netherlands where the International Workshop on Clinical Pharmacology of HIV Therapy started.  We hope you will be able to join us in this important conference and we look forward to seeing you in Amsterdam!

Dr. Marta Boffito - Chelsea and Westminster Hospital, UK
Dr. Steve Taylor - Birmingham Heartlands Hospital, UK
Challenging Cases (drug interactions, pregnancy, stopping drugs with different half times)

Dr. Ed Acosta - Univ. of Alabama at Birmingham, USA
Dr. Chantal Csajka - Centre Hospitalier Universitaire Vaudois, Switzerland
Dr. Rick Bertz - Bristol-Myers Squibb, USA
Roundtable - New Models of Drug Action

Dr. Elisabeth Rook - EMEA, The Netherlands
Dr. John Morris - Abbott Laboratories, USA
Roundtable - Challenges in Pediatric Formulations and Dose Selection

Dr. Craig Hendrix - Johns Hopkins University, USA
Prevention of HIV Transmission - PrEP

Dr. David Margolis - Univ. of North Carolina at Chapel Hill, USA
Curing HIV: Pharmacologic Approaches to Target Latency

Dr. Charles Flexner - Johns Hopkins University, USA
Pharmacology of Aging

Dr. Saye Khoo - University of Liverpool, United Kingdom
Challenges with Malaria Co-infection

Dr. T. Arien - Johnson & Johnson Pharmaceutical R&D, Belgium
NanoTechnology, the Promises and Challenges for ARV nanotechnology

Deadline for early registration: 15 January 2009
Deadline for abstract submission: 20 February 2009

The members of the Organizing Committee:
David Burger, University Hospital Nijmegen, The Netherlands (chair 2009)
Angela Kashuba, Univ. of North Carolina at Chapel Hill, USA (chair 2009)
David Back, University of Liverpool, United Kingdom
Terrence Blaschke, Standford University School of Medicine, USA
Charles Boucher, Erasmus Medical Center, The Netherlands
Courtney Fletcher, University of Nebraska, USA
Charles Flexner, Johns Hopkins University, USA
Jonathan Schapiro, Sheba Medical Center, Israel

look forward to seeing you in Amsterdam.

More information is available on our website: www.virology-education.com